Refresh

Orchid Pharma Ltd. - Research Center

524372 ORCHPHARMA Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

819.37 665.90 556.97 450.70 505.45
Expenses

Material consumed

498.39 397.18 326.80 240.76 263.64

Manufacturing expenses

62.92 61.26 52.74 39.31 52.74

Personnel expenses

69.64 65.35 60.21 64.40 81.48

Selling expenses

0.03 0.04 0.04 0.02 0.02

Adminstrative expenses

77.70 58.45 59.93 48.31 151.84

Expenses capitalised

- - - - -

Cost of sales

708.69 582.28 499.72 392.81 549.71

Operating profit

110.68 83.62 57.26 57.89 -44.26

Other recurring income

30.39 19.43 9.00 6.48 24.49

Adjusted PBDIT

141.07 103.05 66.26 64.36 -19.78

Financial expenses

16.33 32.23 87.02 51.34 4.16

Depreciation

33.22 54.79 32.01 108.90 125.90

Other write offs

- - - - -

Adjusted PBT

91.52 16.04 -52.77 -95.87 -149.84

Tax charges

-3.23 - - - -

Adjusted PAT

94.75 - - - -

Non recurring items

- 38.15 47.96 -21.28 88.56

Other non cash adjustments

- - - - -

Reported net profit

94.75 54.19 -4.81 -117.15 -61.28

Earnigs before appropriation

-1,987.93 -2,082.45 -2,138.10 -2,133.89 -2,014.85

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-1,987.93 -2,082.45 -2,138.10 -2,133.89 -2,014.85
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com